Mitochondrial dysfunction, apoptotic cell death, and Alzheimer's disease

被引:270
作者
Eckert, A [1 ]
Keil, U [1 ]
Marques, CA [1 ]
Bonert, A [1 ]
Frey, C [1 ]
Schüssel, K [1 ]
Müller, WE [1 ]
机构
[1] Goethe Univ Frankfurt, Bioctr, Dept Pharmacol, D-60439 Frankfurt, Germany
关键词
APP mutation; beta-amyloid; caspases; oxidative stress; mitochondria; cell death;
D O I
10.1016/S0006-2952(03)00534-3
中图分类号
R9 [药学];
学科分类号
1007 ;
摘要
Being major sources of reactive oxygen species (ROS), mitochondrial structures are exposed to high concentrations of ROS and might therefore be particularly susceptible to oxidative injury. Mitochondrial damage may play a pivotal role in the cell death decision. Bolstered evidence indicates that mitochondrial abnormalities might be part of the spectrum of chronic oxidative stress occurring in Alzheimer's disease (AD) finally contributing to synaptic failure and neuronal degeneration. Accumulation and oligomerization of amyloid beta (A) is also thought to play a central role in the pathogenesis of this disease by probably directly leading to mitochondrial dysfunction. Moreover, numerous lines of findings indicate increased susceptibility to apoptotic cell death and increased oxidative damage as common features in neurons from sporadic AD patients but also from familial AD (FAD) cases. Here we provide a summary of recent work demonstrating some key abnormalities that may initiate and promote pathological events in AD. Finally, we emphasize a hypothetical sequence of the pathogenic steps linking sporadic AD, FAD, and Abeta production with mitochondrial dysfunction, caspase pathway, and neuronal loss. (C) 2003 Elsevier Inc. All rights reserved.
引用
收藏
页码:1627 / 1634
页数:8
相关论文
共 92 条
[1]   Both oxidative stress-dependent and independent effects of amyloid β protein are detected by 3-(4,5-dimethylthiazol-2-yl)-2,5-diphenyltetrazolium bromide (MTT) reduction assay [J].
Abe, K ;
Saito, H .
BRAIN RESEARCH, 1999, 830 (01) :146-154
[2]   SEQUENCE AND ORGANIZATION OF THE HUMAN MITOCHONDRIAL GENOME [J].
ANDERSON, S ;
BANKIER, AT ;
BARRELL, BG ;
DEBRUIJN, MHL ;
COULSON, AR ;
DROUIN, J ;
EPERON, IC ;
NIERLICH, DP ;
ROE, BA ;
SANGER, F ;
SCHREIER, PH ;
SMITH, AJH ;
STADEN, R ;
YOUNG, IG .
NATURE, 1981, 290 (5806) :457-465
[3]   Mitochondria, free radicals, and neurodegeneration [J].
Beal, MF .
CURRENT OPINION IN NEUROBIOLOGY, 1996, 6 (05) :661-666
[4]  
BLASS JP, 1991, REV NEUROL, V147, P513
[5]   Cytochrome c oxidase and mitochondrial F1F0-ATPase (ATP synthase) activities in platelets and brain from patients with Alzheimer's disease [J].
Bosetti, F ;
Brizzi, F ;
Barogi, S ;
Mancuso, M ;
Siciliano, G ;
Tendi, EA ;
Murri, L ;
Rapoport, SI ;
Solaini, G .
NEUROBIOLOGY OF AGING, 2002, 23 (03) :371-376
[6]   NO says yes to mitochondria [J].
Brown, GC .
SCIENCE, 2003, 299 (5608) :838-839
[7]  
Bruce-Keller AJ, 1998, J NEUROCHEM, V70, P31
[8]   BETA-AMYLOID PEPTIDE FREE-RADICAL FRAGMENTS INITIATE SYNAPTOSOMAL LIPOPEROXIDATION IN A SEQUENCE-SPECIFIC FASHION - IMPLICATIONS TO ALZHEIMERS-DISEASE [J].
BUTTERFIELD, DA ;
HENSLEY, K ;
HARRIS, M ;
MATTSON, M ;
CARNEY, J .
BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS, 1994, 200 (02) :710-715
[9]   β-amyloid inhibits integrated mitochondrial respiration and key enzyme activities [J].
Casley, CS ;
Canevari, L ;
Land, JM ;
Clark, JB ;
Sharpe, MA .
JOURNAL OF NEUROCHEMISTRY, 2002, 80 (01) :91-100
[10]   Role of mitochondrial dysfunction in Alzheimer's disease [J].
Castellani, R ;
Hirai, K ;
Aliev, G ;
Drew, KL ;
Nunomura, A ;
Takeda, A ;
Cash, AD ;
Obrenovich, ME ;
Perry, G ;
Smith, MA .
JOURNAL OF NEUROSCIENCE RESEARCH, 2002, 70 (03) :357-360